A study in the United States involving 5,370 adults found the prevalence of non-alcoholic fatty liver disease with increasing levels of SUA (33), and patients with HUA were more likely to have elevated levels of ALT and AST (33, 34). The gene discussed is GPT; the disease is metabolic dysfunction-associated steatotic liver disease.